Audited Results of Novartis India Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	356.27	335.07	378.74	399.87	381.35
Manufacturing Expenses	0.14	0.18	0.35	0.53	0.53
Personnel Expenses	18.72	22.96	35.64	101.89	108.51
Selling Expenses	2.34	1.94	6.10	7.46	9.80
Administrative Expenses	40.83	44.89	69.88	84.75	89.10
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	264.85	269.81	313.66	372.76	354.56
Operating Profit	91.42	65.26	65.08	27.11	26.79
Other Recurring Income	41.96	61.68	58.11	33.19	33.09
Adjusted PBDIT	133.38	126.94	123.19	60.30	59.88
Financial Expenses	0.77	1.49	1.75	4.83	7.68
Depreciation	2.19	2.61	6.06	9.65	12.16
Other Write offs	0	0	0	0	0
Adjusted PBT	130.42	122.84	115.38	45.82	40.04
Tax Charges	29.52	37.65	12.02	-0.10	19.14
Adjusted PAT	100.90	85.19	103.36	45.92	20.90
Non Recurring Items	0.97	1.21	3.11	-41.45	-6.09
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	100.90	85.19	103.36	-3.72	20.90
Equity Dividend	61.73	117.28	24.69	24.69	24.69
Preference Dividend	0	0	0	0	0
Retained Earnings	768.98	728.84	759.72	677.94	698.16

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article